1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCollaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) is sponsored by NIH National Institute of General Medical Sciences (NIGMS). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Collaborative Program Grant for Multidisciplinary Teams (RM1) | National Institute of General Medical Sciences Team science can achieve outcomes that may not be possible through the efforts of individual laboratories.
The NIGMS Collaborative Program Grant for Multidisciplinary Teams (RM1) supports applications from a highly integrated team of investigators addressing a single-focused, ambitious, and challenging project that cannot be addressed by individual R01 applications. The RM1 is a single application and not a collection of sub-projects. The proposed RM1 team must comprise of three to six principal investigators.
The research topic must be central to the NIGMS mission areas and projects should not be achievable by individual efforts. The RM1 program requires the participation of multiple investigators with complementary expertise to achieve the team's research objectives. Applications must have well-defined goals that can be achieved within 5-10 years.
The team of researchers can be located at a single institution or multiple institutions throughout the United States. A fully integrated team of investigators will have shared management responsibility. Teams have the option to request development funds in year 2-5 to add Early Stage Investigators with complementary expertise to the program.
For additional information on the NIGMS Collaborative Program Grant for Multidisciplinary Teams (RM1), please contact Oleg Barski, Ph. D. and Chi-Wing Chow, Ph.
D. at RM1mailbox@nigms. nih.
gov . For more information on the Biomedical Technology Optimization and Dissemination Centers (RM1), visit the BTOD page .
PAR-23-077 Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) FAQs About PAR-23-077 Collaborative Program Grant for Multidisciplinary Teams Webinar on Funding Announcements for Team Science and Biomedical Technology Development and Dissemination Centers Funded Research for Collaborative Teams RM1 Considerations for Multiple Principal Investigator (MPI) Applications Feedback Loop Posts on Team Science This page last updated on
According to the current listing, eligibility includes: Domestic institutions/organizations with multidisciplinary research teams. Non-domestic (non-U. S.) Entities are not eligible to apply. Confirm the full requirements in the official notice before applying.
The current listing shows unspecified (up to five years of support, plus optional developmental funds of $250,000 direct costs per year for ESIs). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) is funded by NIH National Institute of General Medical Sciences (NIGMS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articlePAR-27-054 and PAR-27-055 replace COBRE's Phase 1-2-3 model with two tracks: a 15-year Development-Expansion-Sustainability path and a 10-year Expansion-Sustainability path. At $1.5 million per year in direct costs across 23 states and Puerto Rico, with new research cores prohibited in the final phase and eligibility capped at three active awards per institution, the track you claim is the most consequential choice in the application.
Read article